Bone Biologics (BBLG) Total Current Liabilities (2013 - 2025)
Bone Biologics (BBLG) reported Total Current Liabilities of $418587.0 for Q4 2025, up 10.82% year-over-year from $377712.0 in Q4 2024, and up 25.22% quarter-over-quarter from $334282.0 in Q3 2025.
Bone Biologics (BBLG) Total Current Liabilities (2013 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 13 years of Total Current Liabilities data on file, last reported at $418587.0 in Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $418587.0, up 10.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $418587.0 (up 10.82% YoY), and the FY2025 annual result was $418587.0, up 10.82% from the prior year.
- Total Current Liabilities climbed to $418587.0 in Q4 2025 per BBLG's latest filing, from $334282.0 in the prior quarter.
- Over five years, Total Current Liabilities peaked at $4.0 million in Q1 2023 and troughed at $99909.0 in Q4 2021.
- A 5-year average of $936750.0 and a median of $391927.0 in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2021 and 2022: Total Current Liabilities tumbled 99.27% in 2021, then jumped 2450.25% in 2022.
- A 5-year view of Total Current Liabilities shows it stood at $99909.0 in 2021, then jumped by 2450.25% to $2.5 million in 2022, then slumped by 67.37% to $831402.0 in 2023, then sank by 54.57% to $377712.0 in 2024, then increased by 10.82% to $418587.0 in 2025.
- Business Quant data shows BBLG's Total Current Liabilities at $418587.0 in Q4 2025, $334282.0 in Q3 2025, and $406142.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 72.86 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | 418,587.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 418,587.00 |
| Sep 30, 2025 | 334,282.00 |
| Jun 30, 2025 | 406,142.00 |
| Mar 31, 2025 | 251,158.00 |
| Dec 31, 2024 | 377,712.00 |
| Sep 30, 2024 | 273,402.00 |
| Jun 30, 2024 | 284,507.00 |
| Mar 31, 2024 | 164,626.00 |
| Dec 31, 2023 | 831,402.00 |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | 4.01 Mn |
| Dec 31, 2022 | 2.55 Mn |
| Dec 31, 2021 | 99,909.00 |
| Dec 31, 2020 | 13.69 Mn |
| Sep 30, 2020 | 13.24 Mn |
| Jun 30, 2020 | 12.85 Mn |
| Mar 31, 2020 | 12.47 Mn |
| Dec 31, 2019 | 578,447.00 |
| Sep 30, 2019 | 11.63 Mn |